NEW YORK, Feb. 6, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aratana Therapeutics, Inc. ("Aratana" or the "Company") (NASDAQ: PETX ). Such investors are advised to contact Robert S. Willoughby at or 888-476-6529, ext. 9980.